JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area dna damage dna hdac'

Search results for: 'research area dna damage dna hdac'

A4098 PCI-24781 (CRA-024781)

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL
A4099 Valproic acid sodium salt (Sodium valproate)

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥8.35 mg/mL
A4090 JNJ-26481585

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4496 NSC 3852

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
A4084 Vorinostat (SAHA, MK0683)

9 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4107 Sodium Phenylbutyrate

Target: Histone Deacetylases (HDACs)

Summary: Histone deacetylase inhibitor

≥27.65 mg/mL
A4497 Pyroxamide

Target: Histone Deacetylases (HDACs)

Summary: HDAC1 inhibitor

Soluble in DMSO
A4089 Mocetinostat (MGCD0103, MG0103)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
B1399 Temozolomide

Summary: DNA methylating, chemotherapeutic agent

insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL
A4091 PCI-34051

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC8 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL